Dechra sales receive North American boost

The veterinary pharma specialist reports strong trading and a potential US tax benefit
Thursday 11 Jan 2018 Author: Lisa-Marie Janes
Dechra Pharmaceuticals ( DPH ) £20.58 Gain to date: 19% Original entry point: Buy at £17.29, 27 July 2017 Veterinary products developer Dechra Pharmaceuticals ( DPH ) continues to deliver strong trading with a 10.5% jump in sales in the second half of 2017. The upbeat performance was driven by a 20% increase in North American sales and a return to growth in Europe of 5.5%. Dechra has registered...

Important information:

These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell Youinvest.

Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.

Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.

The Shares team

Advertising feature

The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.